美國居民不適用 XM 服務。
G
G

GSK

交易方向

交易者脈動

技術摘要

小時

財經新聞

Iteos And GSK Initiate Phase 3 Study Assessing Belrestotug And Dostarlimab In Non-Small Cell Lung Cancer

BRIEF-Iteos And GSK Initiate Phase 3 Study Assessing Belrestotug And Dostarlimab In Non-Small Cell Lung Cancer June 17 (Reuters) - GSK plc GSK.L : ITEOS AND GSK INITIATE GALAXIES LUNG-301 PHASE 3 STUDY, ASSESSING BELRESTOTUG AND DOSTARLIMAB IN PREVIOUSLY UNTREATED, UNRESECTABLE LOCALLY ADVANCED / METASTATIC PD-L1 SELECTED NON-SMALL CELL LUNG CANCER
G

New Pharma will crowd out Big Pharma

BREAKINGVIEWS-New Pharma will crowd out Big Pharma The author is a Reuters Breakingviews columnist. The opinions expressed are her own. By Aimee Donnellan LONDON, June 11 (Reuters Breakingviews) - Big Pharma is under threat from tech-driven upstart rivals. The values of large, established players like $159 billion Pfizer PFE.N , $230 billion Novartis NOVN.S and $216 billion Roche ROG.S are converging with newer players like $121 billion Vertex Pharmaceuticals VRTX.O .
A
G
N
P
R
R
S
V

GSK Files Application Seeking Right Of Appeal To Delaware Supreme Court On Zantac Litigation

BRIEF-GSK Files Application Seeking Right Of Appeal To Delaware Supreme Court On Zantac Litigation June 11 (Reuters) - GSK plc GSK.L : STATEMENT: ZANTAC (RANITIDINE) LITIGATION DELAWARE SUPERIOR COURT'S RULING INCONSISTENT WITH HOW DAUBERT STANDARD* HAS PREVIOUSLY BEEN APPLIED IN DELAWARE AND FEDERAL COURTS APPLICATION HAS BEEN FILED SEEKING RIGHT
G

British Business - June 11

PRESS DIGEST-British Business - June 11 June 11 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times - GSK GSK.L and other drugmakers on Monday asked a Delaware court for permission to appeal a ruling allowing more than 70,000 lawsuits claiming that heartburn drug Zantac causes cancer to go forward.
B
B
B
G
P

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

UPDATE 1-GSK asks to appeal Delaware ruling allowing Zantac cases to go forward Recasts headline, paragraphs 1-4 with appeal petition By Brendan Pierson June 10 (Reuters) - GSK GSK.L and other drugmakers on Monday asked a Delaware court for permission to appeal a ruling allowing more than 70,000 lawsuits claiming that heartburn drug Zantac causes cancer to go forward.
G
P
S

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明